Researchers used AI to design a short peptide aimed at cells that have stopped dividing, which build up with age and in response to DNA damage.
Recap by typeshit. Full story at Business Today on MSN.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Marchione makes the case for pairing GLP-1s with drugs that target amylin, the hormone released after meals that signals fullness to the brain.
Regen says the placebo group saw a 9% drop, while people on retatrutide also lost 31 lb on average and saw systolic blood pressure fall 14 points.
He points to a November 2026 study he says suggests semaglutide and other GLP-1 drugs may help beyond diabetes and obesity in people with schizophrenia.
Healio
ACOG says up to 1 in 300 women are exposed before pregnancy. It advises discussing contraception and, for those who breastfeed, shorter acting drugs and watching infant weight.
Loading…